Source: Clinical Trials Arena Diversity is a growing concern in all aspects of modern life, but the ramifications of this disparity in health care can
MANASSAS, VA. (PRWEB) DECEMBER 01, 2021 The ongoing COVID-19 pandemic ranks as perhaps the most serious global health crisis of the past hundred years. Worldwide,
Source: Relias Media IRBs are seeing a surge in study protocols that include remote recruitment, consent, and participation, raising ethical and regulatory considerations for investigators.
Source: HR.com Serious inefficiencies are hampering clinical trials of new drugs and treatments, prolonging the suffering of millions. Today’s platform technologies, says Dr. Harsha Rajasimha
Source: Pharmaceutical Outsourcing The outbreak of the COVID-19 pandemic seriously disrupted new drug testing, treatments, and in-person healthcare services; access to clinical trial sites was
Source: Outsourcing-Pharma Leaders from the trial tech provider discuss how human-focused technology on eClinical platforms can tackle inefficiencies associated with traditional studies. According to Harsha
Serious inefficiencies are hampering clinical trials of new drugs and treatments, prolonging the suffering of millions. Today’s platform technologies, says Dr. Harsha Rajasimha of Jeeva
Source: eurweb.com Did you know that 80% of participants of randomized, controlled clinical trials are Caucasian males or that less than 10% of those trials
Source: ACRP The clinical trial industry must proactively address a record of “historical errors and misbehavior” in its treatment of minority populations if it wants
Traditional clinical guidelines, and stand-alone patient study and care pathways are proven to be increasingly inadequate, especially in a post-pandemic world with low clinical adherence,
Jeeva Clinical Trials Inc.
